Financials

  • Market Capitalization 1.77 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.15
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2076
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.38 USD+1.20%-7.40%+3.36%-36.11%1.79 B USD
2077
PGEN
Precigen, Inc. - Common Stock
5.11 USD-0.20%-6.75%+6.24%+174.73%1.82 B USD
2117
IMCR
Immunocore Holdings plc - American Depositary Shares
33.43 USD-0.12%+1.18%+16.85%-0.15%1.70 B USD
2120
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
6.75 USD+3.69%+18.42%+36.09%+158.62%1.74 B USD